Dana Cucu

Dr. Dana Cucu

University of Bucharest, Faculty of Biology, Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAndrei Sorop
Andrei Sorop
DCDiana Constantinescu
Diana Constantinescu
FCFlorentina Cojocaru
Florentina Cojocaru
Anca DinischiotuAnca Dinischiotu
Anca Dinischiotu
DCDana Cucu
Dana Cucu
DODima Simona Olimpia
Dima Simona Olimpia
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second most common cause of cancer-related death globally. This type of liver cancer is frequently detected at a late stage by current biomarkers because of the high clinical and biological heterogeneity of HCC tumours. From a plethora of molecules and cellular compounds, small nanoparticles with an endosomal origin are valuable cancer biomarkers or cargos for novel treatments. Despite their small sizes, in the range of 40–150 nm, these particles are delimited by a lipid bilayer membrane with a specific lipid composition and carry functional information—RNA, proteins, miRNAs, long non-coding RNAs (lncRNAs), or DNA fragments. This review summarizes the role of exosomal microRNA (miRNA) species as biomarkers in HCC therapy. After we briefly introduce the exosome biogenesis and the methods of isolation and characterization, we discuss miRNA’s correlation with the diagnosis and prognosis of HCC, either as single miRNA species, or as specific panels with greater clinical impact. We also review the role of exosomal miRNAs in the tumourigenic process and in the cell communication pathways through the delivery of cargos, including proteins or specific drugs.

23 June 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
FPFlorentina Piciu
Florentina Piciu
Mihaela BalasMihaela Balas
Mihaela Balas
Madalina Andreea BadeaMadalina Andreea Badea
Madalina Andreea Badea
DCDana Cucu
Dana Cucu
The channels from the superfamily of transient receptor potential (TRP) activated by reactive oxygen species (ROS) can be defined as redox channels. Those with the best exposure of the cysteine residues and, hence, the most sensitive to oxidative stress are TRPC4, TRPC5, TRPV1, TRPV4, and TRPA1, while others, such as TRPC3, TRPM2, and TRPM7, are indirectly activated by ROS. Furthermore, activation by ROS has different effects on the tumorigenic process: some TRP channels may, upon activation, stimulate proliferation, apoptosis, or migration of cancer cells, while others inhibit these processes, depending on the cancer type, tumoral microenvironment, and, finally, on the methods used for evaluation. Therefore, using these polymodal proteins as therapeutic targets is still an unmet need, despite their draggability and modulation by simple and mostly unharmful compounds. This review intended to create some cellular models of the interaction between oxidative stress, TRP channels, and inflammation. Although somewhat crosstalk between the three actors was rather theoretical, we intended to gather the recently published data and proposed pathways of cancer inhibition using modulators of TRP proteins, hoping that the experimental data corroborated clinical information may finally bring the results from the bench to the bedside.

1 July 2014 in Pancreas
Verified
Journal Article
Closed access
DCDana Cucu
Dana Cucu
GCGabriela Chiritoiu
Gabriela Chiritoiu
SPStefana M. Petrescu
Stefana M. Petrescu
ABAlexandru Babes
Alexandru Babes
LSLuciana Msc Stanica
Luciana Msc Stanica
IPIrinel MD Popescu
Irinel MD Popescu
Objective Recently, the transient receptor potential melastatin 8 (TRPM8) channel has emerged as a putative biomarker for pancreatic ductal adenocarcinoma (PDA). This study aimed to evaluate the expression of TRPM8 and its modulation by specific agonists and antagonists in PDA cells. Methods We examined the protein expression of TRPM8 in 3 different PDA cell lines and compared it with a nontumoral epithelial cell line of human pancreatic origin using Western blotting and immunocytochemical analysis. To assess the function of TRPM8 channels, we measured the TRPM8 currents in whole-cell mode of the patch clamp technique. To explore the putative involvement of TRPM8 in cell migration, we investigated the motility of PDA cells using the scratch-wound assay. Results Pancreatic ductal adenocarcinoma cells express functional plasma membrane TRPM8 channels, which are responsive after exposure to agonists (menthol and icilin) and antagonists N-(3-aminopropyl)-2-{[(3-methylphenyl) methyl]oxy}-N-(2-thienylmethyl)benzamide hydrochloride salt. The silencing of TRPM8 expression by small interfering RNA augments the migration of PDA cells. Conversely, the activated form of TRPM8 inhibits PDA cell motility. Conclusions An unglycosylated TRPM8 protein is expressed and is functional in the membrane of PDA cells. Transient receptor potential melastatin 8 inhibits the migration of PDA cells, suggesting a putative role as a biomarker or target for this channel for PDA therapy.

21 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FCFlorentina Cojocaru
Florentina Cojocaru
TSTudor Selescu
Tudor Selescu
DDDan Domocoş
Dan Domocoş
Luminita MarutescuLuminita Marutescu
Luminita Marutescu
GCGabriela Chiritoiu
Gabriela Chiritoiu
DCDana Cucu
Dana Cucu
The transient receptor potential ankyrin type 1 (TRPA1) channel belongs to the TRP superfamily of ion channels. TRPA1 is a membrane protein with multiple functions able to respond to noxious stimuli, reactive oxygen species, inflammatory cytokines or pungent substances, and it participates in pain signalling, taste, inflammation and various steps of the tumorigenic process. To date, no reports have addressed the expression and function of TRPA1 in pancreatic ductal adenocarcinoma (PDAC) cells. This work reports the endogenous expression of TRPA1 channels in human pancreatic adenocarcinoma cell lines and provides insights into the function of the TRPA1 protein in the Panc-1 cell line. This study reports that cell lines isolated from PDAC patients had different levels of TRPA1 expression. The channel activity in Panc-1 cells, as assessed with electrophysiological (whole-cell patch clamp) and microfluorimetry methods, showed that non-selective cationic currents were activated by allyl isothiocyanate (AITC) in Panc-1 cells and inhibited by the selective TRPA1 antagonist A-967079. The current elicited by the specific agonist was associated with a robust increase in intracellular Ca2+. Furthermore, siRNA-induced downregulation of TRPA1 enhanced cell migration in the wound healing assay, indicating a possible role of ion channels independent from pore function. Finally, TRPA1 activation changed the cell cycle progression. Taken together, these results support the idea of channel-dependent and independent role for TRPA1 in tumoral processes.

4 March 2002 in FEBS Letters
Verified
Journal Article
Closed access
ASAndrei Segal
Andrei Segal
DCDana Cucu
Dana Cucu
WDWilly Van Driessche
Willy Van Driessche
WWWolf-Michael Weber
Wolf-Michael Weber

1 March 2010 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Szilveszter GasparSzilveszter Gaspar
Szilveszter Gaspar
CNCristina Niculiţe
Cristina Niculiţe
DCDana Cucu
Dana Cucu
IMIrene Marcu
Irene Marcu